HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites

por Rojas, P, Epp, C, Gozzo, L, Geba, D, Epstein, M, Michel, S
Publicado 2022

Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries

por Olimpieri, P.P., Di Lenarda, A., Mammarella, F., Gozzo, L., Cirilli, A., Cuomo, M., Gulizia, M.M., Colivicchi, F., Murri, G., Gabrielli, D., Trotta, F.
Publicado 2020

Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation

por Gozzo, L., Di Lenarda, A., Mammarella, F., Olimpieri, P. P., Cirilli, A., Cuomo, M., Gulizia, M. M., Colivicchi, F., Murri, G., Kunutsor, S. K., Gabrielli, D., Trotta, F.
Publicado 2021